{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:06:19Z","timestamp":1790175979080,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute for Pharmaceutical Research and Development (NIPRD), Abuja, Nigeria"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.pnpbp.2012.04.018","type":"journal-article","created":{"date-parts":[[2012,4,27]],"date-time":"2012-04-27T00:45:49Z","timestamp":1335487549000},"page":"310-316","source":"Crossref","is-referenced-by-count":64,"title":["Ketamine-enhanced immobility in forced swim test: A possible animal model for the negative symptoms of schizophrenia"],"prefix":"10.1016","volume":"38","author":[{"given":"Ben A.","family":"Chindo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulus","family":"Adzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tijani A.","family":"Yahaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karniyus S.","family":"Gamaniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2012.04.018_bb0005","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.pbb.2004.01.020","article-title":"Behavioral effects of Pavetta Crassipes extracts on rodent","volume":"77","author":"Amos","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000418013","article-title":"Methods for assessing positive and negative symptoms of schizophrenia","volume":"24","author":"Andreasen","year":"1990","journal-title":"Mod Probl Pharmacopsychiatry"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0010","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(95)91325-4","article-title":"Symptoms, signs, and diagnosis of schizophrenia","volume":"346","author":"Andreasen","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0020","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1476-5381.1983.tb11031.x","article-title":"The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate","volume":"79","author":"Anis","year":"1983","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0025","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1192\/bjp.154.4.486","article-title":"The nature and prevalence of depression in chronic schizophrenic in patients","volume":"154","author":"Barnes","year":"1989","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0030","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.pnpbp.2004.06.019","article-title":"Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity","volume":"28","author":"Becker","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0035","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0278-5846(03)00080-0","article-title":"Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia","volume":"27","author":"Becker","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0040","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/schbul\/14.2.297","article-title":"The role of serotonin in schizophrenia","volume":"14","author":"Bleich","year":"1988","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0045","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000418016","article-title":"Treatment of positive and negative symptoms: pharmacologic approaches","volume":"24","author":"Boyer","year":"1990","journal-title":"Mod Probl Pharmacopsychiatry"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0050","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1023\/A:1021694307672","article-title":"Differences in measure of exploration and fear in mhc-congenic C57BL\/6J and B6-H-2K mice","volume":"26","author":"Brown","year":"1999","journal-title":"Behav Genet"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0055","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00428197","article-title":"Effects of serotonin antagonism in schizophrenia: a pilot study with setoperone","volume":"85","author":"Ceulemans","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbr.2010.08.001","article-title":"Effect of \u2018chronic\u2019 versus \u2018acute\u2019 ketamine administration and its \u2018withdrawal\u2019 effect on behavioural alterations in mice: implications for experimental psychosis","volume":"216","author":"Chatterjee","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0065","unstructured":"Chindo B.A., 2006. Pharmacological studies on the saponin fractions of Ficus platyphylla. An unpublished PhD thesis. Ahmadu Bello University, Zaria, Nigeria."},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0070","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0378-8741(02)00376-8","article-title":"Central nervous system activity of the methanol extract of Ficus platyphylla stem bark","volume":"85","author":"Chindo","year":"2003","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0075","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00004714-199302000-00004","article-title":"A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients","volume":"13","author":"Chouinard","year":"1993","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0080","doi-asserted-by":"crossref","first-page":"S211","DOI":"10.1016\/S0893-133X(99)00128-1","article-title":"Animal models of negative symptoms: M100907 antagonizes PCP-induced immobility in a forced swim test in mice","volume":"21","author":"Corbett","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0085","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1196\/annals.1300.020","article-title":"Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia","volume":"1003","author":"Coyle","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0440","series-title":"Pharmacotherapy: a pathophysiologic approach","first-page":"1099","article-title":"Schizophrenia","author":"Crismon","year":"2008"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0445","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0166-4328(96)00067-8","article-title":"Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth","volume":"73","author":"Detke","year":"1996","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0095","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00002826-200101000-00008","article-title":"A revised excitotoxic hypothesis of schizophrenia: therapeutic implications","volume":"24","author":"Deutsch","year":"2001","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0115","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/00005053-199112000-00006","article-title":"Neuropsychological deficits in chronic schizophrenics. Relationship with symptoms and behaviour","volume":"178","author":"Dickerson","year":"1991","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00213-004-2109-y","article-title":"Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia","volume":"179","author":"Egerton","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0125","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0165-0173(94)00014-G","article-title":"The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias","volume":"20","author":"Ellison","year":"1995","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0130","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1358\/mf.2007.29.4.1075358","article-title":"Phencyclidine and genetic animal models of schizophrenia developed in relation to the glutamate hypothesis","volume":"29","author":"Enomoto","year":"2007","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0135","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.pnpbp.2007.08.025","article-title":"The amphetamine-induced sensitized state as a model of schizophrenia","volume":"31","author":"Featherstone","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0140","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bbr.2007.12.032","article-title":"A sensitizing regimen of amphetamine that disrupts attentional set-shifting does not disrupt working or long-term memory","volume":"189","author":"Featherstone","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0145","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archpsyc.1992.01820030011002","article-title":"Testing system for assessment of negative symptoms in schizophrenia","volume":"49","author":"Fenton","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0150","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJMra035458","article-title":"Schizophrenia","volume":"349","author":"Freedman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0155","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pnpbp.2007.07.027","article-title":"Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus","volume":"32","author":"Garcia","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0160","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.pnpbp.2003.09.003","article-title":"Animal behavior models of the mechanisms underlying antipsychotic atypicality","volume":"27","author":"Geyer","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0165","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1176\/appi.ajp.158.9.1367","article-title":"The emerging role of glutamate in the pathophysiology and treatment of schizophrenia","volume":"158","author":"Goff","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0170","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0006-3223(97)00321-1","article-title":"Alterations in the cortical serotonergic system in schizophrenia: a postmortem study","volume":"42","author":"Gurevich","year":"1997","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0175","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/schbul\/sbj011","article-title":"Negative symptoms and cognitive deficits: what is the nature of their relationship?","volume":"32","author":"Harvey","year":"2006","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0180","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1176\/ajp.147.2.255b","article-title":"Single photon emission computed tomography in phencyclidine and related drug abuse","volume":"147","author":"Hertzmann","year":"1990","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0185","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/bja\/77.4.441","article-title":"Ketamine: its mechanism(s) of action and unusual clinical uses","volume":"77","author":"Hirota","year":"1996","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0190","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.brainresbull.2006.01.010","article-title":"Dose\u2013response characteristics of ketamine effect on locomotion, cognitive function and central neuronal activity","volume":"69","author":"Imre","year":"2006","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0195","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0091-3057(03)00130-8","article-title":"Clitoria ternatea and the central nervous system","volume":"75","author":"Jain","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0200","first-page":"685","article-title":"Pharmacology of risperidone (R6466). A new antipsychotic with 5HT2 and dopamine-D2 antagonistic properties","volume":"244","author":"Jansen","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0205","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0210","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0893-133X(98)00060-8","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0215","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1476-5381.2011.01386.x","article-title":"Animal models of schizophrenia","volume":"164","author":"Jones","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0220","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.pnpbp.2007.09.008","article-title":"Comparison between intraperitoneal and subcutaneous phencyclidine administration in Sprague\u2013Dawley rats: a locomotor activity and gene induction study","volume":"32","author":"Kalinichev","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0225","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJM199601043340109","article-title":"Schizophrenia","volume":"334","author":"Kane","year":"1996","journal-title":"New Engl J Med"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0230","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0006-3223(00)00976-8","article-title":"Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia","volume":"48","author":"Kegeles","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0235","first-page":"967","article-title":"Interaction between the forced swimming test and fluoxetine treatment on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the rat","volume":"282","author":"Kirby","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0240","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1254\/jjp.66.181","article-title":"Effects of risperidone on phencyclidine-induced behaviours: comparison with haloperidol and ritanserin","volume":"66","author":"Kitaichi","year":"1994","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0245","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0163-7258(02)00328-5","article-title":"Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment","volume":"97","author":"Konradi","year":"2003","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0250","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0361-9230(01)00473-7","article-title":"Antidepressant-like properties of zinc in rodent forced swim test","volume":"55","author":"Kroczka","year":"2001","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0255","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanaesthetic effects of the non competitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0260","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1055\/s-2007-1000680","article-title":"Negative schizophrenic symptoms and their detection","volume":"59","author":"Kukla","year":"1991","journal-title":"Fortschr Neurol Psychiatr"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0265","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0893-133X(94)00131-I","article-title":"Subanesthetic doses of ketamine stimulate psychosis in schizophrenia","volume":"13","author":"Lahti","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0270","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0304-3940(91)90255-R","article-title":"Behavioural, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat","volume":"128","author":"Lannes","year":"1991","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0275","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0006-3223(99)00257-7","article-title":"Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT","volume":"47","author":"Laruelle","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0280","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1192\/bjp.168.4.432","article-title":"The dimensions of schizophrenia phenomenology","volume":"168","author":"Lenzenweger","year":"1996","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0285","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0896-6273(00)00111-2","article-title":"Catching up on schizophrenia: natural history and neurobiology","volume":"28","author":"Lewis","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0290","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.neuropharm.2011.08.015","article-title":"The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf+\/\u2212 heterozygous null mice","volume":"62","author":"Lindholm","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0295","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0893-133X(95)00137-3","article-title":"NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers","volume":"14","author":"Malhotra","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0300","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0893-133X(97)00036-5","article-title":"Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics","volume":"17","author":"Malhotra","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0305","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0893-133X(89)90035-3","article-title":"Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat","volume":"2","author":"Mansbach","year":"1989","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0310","first-page":"197","article-title":"Open-field behavior in rats with frontomedial cortical, neostriatal or hippocampal lesions","volume":"41","author":"Markowska","year":"1981","journal-title":"Acta Neurobiol Exp"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0315","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/j.euroneuro.2008.04.002","article-title":"Schizophrenia: from developmental deviance to dopamine dysregulation","volume":"18","author":"Murray","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0320","first-page":"158","article-title":"Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-5HT2 antagonist properties","volume":"264","author":"Oka","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0325","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-3956(99)00029-1","article-title":"NMDA receptor hypofunction model of schizophrenia","volume":"33","author":"Olney","year":"1999","journal-title":"J Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0330","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0944-7113(96)80027-4","article-title":"Effects of Hypericum perforatum L. and Hypericum calycinum L. extracts on the central nervous systems in mice","volume":"3","author":"Ozturk","year":"1996","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0335","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s002130051156","article-title":"Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test","volume":"147","author":"Page","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0340","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1192\/bjp.161.3.335","article-title":"Are there more than two syndromes in schizophrenia? A critique of the positive\u2013negative dichotomy","volume":"161","author":"Peralta","year":"1992","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0345","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0378-8741(98)00059-2","article-title":"Neuropharmacological activity of Solanum nigrum fruit","volume":"62","author":"Perez","year":"1998","journal-title":"J Ethnopharmacol"},{"issue":"10A","key":"10.1016\/j.pnpbp.2012.04.018_bb0450","first-page":"1","article-title":"Rodent models of depression: forced swimming and tail suspension behavioral despair tests in rats and mice","volume":"8","author":"Porsolt","year":"2001","journal-title":"Curr Protoc Neurosci"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0350","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0355","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0014-2999(78)90118-8","article-title":"Behavioural despair in rats: a new model sensitive to antidepressant treatments","volume":"47","author":"Porsolt","year":"1978","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0365","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1176\/ajp.132.10.1076","article-title":"Prolonged psychosis attributed to phencyclidine: report of three cases","volume":"132","author":"Rainey","year":"1975","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0370","series-title":"Harrison's principles of internal medicine","first-page":"2710","article-title":"Mental disorders","author":"Reus","year":"2008"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0375","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-0173(86)90002-0","article-title":"Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis","volume":"396","author":"Robinson","year":"1986","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0380","first-page":"449","article-title":"Anxiolytic like effects of the preferential dopamine D3 receptor agonists in an animal model","volume":"55","author":"Rogoz","year":"2003","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0385","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00008877-199501000-00009","article-title":"Distinct effects of D-amphetamine and phencyclidine on the social behaviour of rats","volume":"6","author":"Sams-Dodd","year":"1995","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0390","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00008877-199601000-00001","article-title":"Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia","volume":"7","author":"Sams-Dodd","year":"1996","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0395","first-page":"112","article-title":"Antidepressant activity of methanolic extract of Passiflora foetida leaves in mice","volume":"3","author":"Santosh","year":"2011","journal-title":"Int J Pharm Pharm Sci"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0400","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00004850-200311000-00001","article-title":"Selective serotonin reuptake inhibitor augmentation in the treatment of negative symptoms of schizophrenia","volume":"18","author":"Silver","year":"2003","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0405","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1192\/bjp.bp.109.067710","article-title":"Efficacy of antidepressants in treating the negative symptoms of chronic schizophrenia: meta-analysis","volume":"197","author":"Singh","year":"2010","journal-title":"Br J Psych"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0455","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1192\/S0007125000293598","article-title":"Glutamatergic aspects of schizophrenia","author":"Tamminga","year":"1999","journal-title":"Br J Psychiatry Suppl"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0415","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1600-0447.1991.tb05562.x","article-title":"Negative symptoms and visual behaviour in DSM\u2010III\u2014R prognostic subtypes of schizophreniform disorder","volume":"83","author":"Troisi","year":"1991","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0420","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/sj.npp.1301586","article-title":"Behavioral and pharmacological validation of the Gerbil Forced-Swim Test: effects of neurokinin-1 receptor antagonists","volume":"33","author":"Wallace-Boone","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0425","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00008877-200305000-00005","article-title":"A comparison of drug effects in latent inhibition and the forced swim test differentiates between the typical antipsychotic haloperidol, the atypical antipsychotics clozapine and olanzapine, and the antidepressants imipramine and paroxetine","volume":"14","author":"Weiner","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0430","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/0006-8993(89)90833-0","article-title":"Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain","volume":"487","author":"Wilmot","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2012.04.018_bb0435","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jep.2011.04.003","article-title":"Behavioral properties of Balanites aegyptiaca in rodents","volume":"135","author":"Ya'u","year":"2011","journal-title":"J Ethnopharmacol"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584612000905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584612000905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:39:27Z","timestamp":1561682367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584612000905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":86,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0278584612000905"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2012.04.018","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}